study guide Flashcards
5-fluorouracil (5-FU):
Target:
Class:
CC phase:
DL SE:
thymidylate synthase
antimetabolite (uridine analog)
S
myelosuppression
5-FU rescue
thymidine
5-FU drug synergy
Leucovorate
5-FU unique resistance mechanism
downregulation of enzyme that convert 5-FU to F-dUMP
increase thymidylate synthase
5-FU genetic testing
5% of pop has polymorphism that results in deficiency of DPD
Cytarabine (Ara-C)
Target:
Class:
CC phase:
DL SE:
- Comp inh of DNA polymerase alpha
- antimetabolite (cytosine analog)
- S phase
- myelosuppression
Cytarabine (Ara-C) synergy
tetrahydrouridine (cytidine deaminase inhibitor)
Cytarabine (Ara-C) resistance mechanisms
downregulation of enzymes that upregulate cytidine deaminase
downregulation of influx transporters
6-Mercaptopurine (6-MP)
Target:
Class:
CC phase:
DL SE:
- multiple enzymes in de novo purine synthesis (blocks synth of purine nucleotides)
- antimetabolite (purine analog, thio-analog of adenine)
- S
- myelosuppression, hematologic toxicity
what drug increases 6-MP toxicity?
allopurinol
unique mechanisms resistance 6-MP
loss of HGPRT (activating enzyme)
6-MP genetic testing
TPMT polymorphism loss of function
methotrexate
Target:
Class:
CC phase:
DL SE:
- DHFR inhibitor
- antifolate
- S
- myelosuppression
methotrexate rescue
Leucovorin
methotrexate resistance mechanism
amplification of DHFR or resistant mutation of DHFR
decreased polyglutamation
Chlorambucil
Target:
Class:
CC phase:
DL SE:
- dna crosslinker
- alkylator
- all phases
- myelosuppression, carcinogenic, teratogenic
unique resistance mechanisms chlorambucil
increase glutathione
increased GST
second malignancies
all antimetabolites/antifolates work in which phase of cell cycle
s
T or F:
all alkylators have risk of second malignancies
true
cyclophosphamide:
Target:
Class:
CC phase:
DL SE:
- DNA crosslinker
- alkylator (prodrug)
- all phases
- hemorrhagic cystitis
what do you give if cyclophosphamide causes hemorrhagic cystitis
mesna
Mitomycin C
Target:
Class:
CC phase:
DL SE:
- bifunctional adducts on DNA
- alkylator (aziridine)
- all phases
- myelosuppression
Cisplatin
Target:
Class:
CC phase:
DL SE:
- covalent crosslinkers of G and A causing strand breaks (forms intrastrands)
- platinum compound
- all phases
- bone marrow, nephrotoxicity (proximal tubule)
T or F:
Cisplatin has a risk of second malignancies
true